English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In recent years, several different multi-marker assays have been developed for the detection of HCC cells in the peripheral blood. This study included 89 Saudi patients with chronic HCV and 30 ages and sex matched healthy control subjects. MAGE-1 mRNA was expressed in the peripheral blood of 3(13.6%) patients with localized HCC and in 9(40.9%) patients with metastatic HCC. MAGE-3 mRNA was expressed in the peripheral blood of 3(13.6%) patients with localized HCC and in 8(42.1%) patients with metastatic HCC. Also, MAGE-4 mRNA was expressed in the peripheral blood of 4(18.1%) patients with localized HCC and in 10(52.6%) patients with metastatic HCC.All control subjects showed no expression of any MAGE mRNAs. In conclusions, MAGE-1, MAGE-3 and MAGE-4 may be promising diagnostic tools for monitoring the prognosis of HCC patients and for early detection of circulating metastasis of HCC cells.

MAGE Genes mRNAs: Potential Early Diagnostic Markers for Hepatocellular Carcinoma in HCV Saudi Patients